The Largest Phase 3 Trial on Psilocybin for Depression Has Kicked Off
The largest Phase 3 clinical trial investigating the efficacy and tolerability of psilocybin for treatment-resistant depression (TRD) has finally begun.
CMPS
Single Dose of Psilocybin Yields Long-Term Depression Remission in Over 50% of Cancer Patients
A single 25mg dose of psilocybin paired with psychological support has resulted in 57% of patients.
Math Over Myth: September Psychedelic Stock News Roundup
Track the monthly performance of the psychedelic stock sector with our Math over Myth Stock News Roundup
End of content
End of content